Chris Sale-Atlanta Braves Agree On Contract Extension

Atlanta Braves pitcher Chris Sale (51) poses for a photo during media day

Chris Sale just became the highest-paid player in Atlanta Braves history for a single season. The 36-year-old lefty agreed to a one-year, $27 million extension with the Braves that also includes a $30 million club option for 2028. It is a move that simultaneously rewards past brilliance and gambles on future health, a combination that defines Sale’s remarkable career arc.

Why the Braves Made This Move

After watching Spencer Schwellenbach and Hurston Waldrep go down with injuries during Spring Training, Atlanta needed rotation insurance. But this extension represents more than a Band-Aid solution. Sale has been great since arriving from Boston in Dec. 2023.

His numbers speak for themselves: 25-8 with a 2.46 ERA across two seasons, including a Cy Young Award in 2024 when he posted a sparkling 2.38 ERA with 225 strikeouts. That performance earned him his first-ever Cy Young trophy after finishing in the top six of voting seven times without taking home the hardware.

The Braves didn’t just extend Sale because he’s been good—they extended him because he’s been healthy. Well, relatively speaking. After years of Tommy John surgery, fractured ribs, broken fingers, and even a bicycle accident, Sale has found a sustainable groove in Atlanta. He’s made 50 appearances over two seasons, proving his lanky 6-foot-6 frame can still hold up under the rigors of a full campaign.

Sale’s Second Act Deserves Appreciation

There’s something poetic about a player resurrecting his career in his mid-thirties. Sale looked finished in Boston. His final three seasons with the Red Sox saw him throw just 151 innings combined. He posted a 4.30 ERA in 2023, and scouts whispered that his fastball had lost its bite. Then Atlanta happened.

His fastball still sits at 95 mph and touches 99. His slider remains one of baseball’s most devastating pitches. Most importantly, the swagger returned. The 2024 Cy Young campaign wasn’t a fluke. His 2025 follow-up, despite a rib injury cutting his season short, showed a 2.58 ERA and a strikeout-to-walk ratio that would make any pitcher jealous (165 Ks to just 32 walks). These aren’t the numbers of a guy hanging on. They’re the numbers of an ace.

The Risk Factor

Paying a 37-year-old pitcher $27 million for one guaranteed season carries inherent risk. Sale’s injury history reads like a medical textbook, and pitchers with his mileage don’t typically age gracefully.

But the Braves structured this deal smartly. The one-year commitment gives them flexibility, while the $30 million option for 2028 provides an easy decision point if Sale falters or gets hurt. If he stays healthy and productive, Atlanta gets another year of elite pitching. If not, they walk away without long-term damage to their payroll.

It’s also worth noting that next winter’s free-agent market for starting pitching looks thin beyond Tarik Skubal. Freddy Peralta, Sandy Alcantara, and Kevin Gausman are solid options; Sale remains in a tier above. The Braves essentially locked in a known commodity rather than gambling on the open market.

What This Means for Atlanta’s 2026 Season

The Braves desperately need this to work. After stumbling to a 76-86 record in 2025, they are trying to reclaim their spot atop the NL East. Sale gives them a legitimate ace to pair with Spencer Strider (assuming he bounces back) and provides veteran leadership to a rotation that suddenly looks young and inexperienced.

His presence also takes pressure off the organization’s pitching depth, which has been tested by early injuries. The Braves can now take a more measured approach with their young arms rather than rushing them to fill rotation spots.

The Bigger Picture

This extension represents something larger than just one player. It’s the Braves’ statement that they’re not rebuilding—they’re retooling on the fly. While other teams tear down and start over, Atlanta is betting that smart extensions, shrewd trades, and homegrown talent can keep them competitive.

Sale’s deal also sets an interesting precedent. The Braves have historically been conservative with single-season salaries, preferring to spread money across longer contracts. By making Sale their highest-paid player for 2027, they’re acknowledging that sometimes you need to pay a premium for proven excellence.